Shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) gapped up before the market opened on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $145.14, but opened at $151.00. Agilent Technologies shares last traded at $155.96, with a volume of 25,071 shares trading hands.
The medical research company reported $1.53 EPS for the quarter, topping the consensus estimate of $1.39 by $0.14. The business had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.21 EPS.
Agilent Technologies Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be issued a $0.225 dividend. The ex-dividend date of this dividend is Friday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.57%. Agilent Technologies’s payout ratio is 19.13%.
Analyst Upgrades and Downgrades
Insider Activity at Agilent Technologies
In related news, CEO Michael R. Mcmullen sold 6,775 shares of the stock in a transaction that occurred on Wednesday, November 16th. The shares were sold at an average price of $148.19, for a total transaction of $1,003,987.25. Following the completion of the sale, the chief executive officer now owns 270,896 shares of the company’s stock, valued at $40,144,078.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 6,775 shares of the company’s stock in a transaction that occurred on Wednesday, November 16th. The shares were sold at an average price of $148.19, for a total transaction of $1,003,987.25. Following the transaction, the chief executive officer now owns 270,896 shares in the company, valued at approximately $40,144,078.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Michael Tang sold 3,600 shares of the company’s stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $139.50, for a total transaction of $502,200.00. Following the transaction, the senior vice president now owns 43,280 shares in the company, valued at approximately $6,037,560. The disclosure for this sale can be found here. Insiders sold 35,309 shares of company stock valued at $4,846,147 over the last 90 days.
Institutional Trading of Agilent Technologies
A number of hedge funds and other institutional investors have recently made changes to their positions in A. Bromfield Sneider Wealth Advisors acquired a new stake in shares of Agilent Technologies in the second quarter worth $31,000. EverSource Wealth Advisors LLC grew its position in Agilent Technologies by 34.8% during the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock valued at $37,000 after buying an additional 77 shares during the period. Edge Capital Group LLC grew its position in Agilent Technologies by 53.0% during the third quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock valued at $37,000 after buying an additional 105 shares during the period. Guardian Wealth Advisors LLC acquired a new stake in Agilent Technologies during the third quarter valued at $42,000. Finally, J.W. Cole Advisors Inc. grew its position in Agilent Technologies by 7,201.6% during the first quarter. J.W. Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock valued at $45,000 after buying an additional 122,788 shares during the period.
Agilent Technologies Trading Up 8.1 %
The company has a market cap of $46.44 billion, a price-to-earnings ratio of 35.73, a price-to-earnings-growth ratio of 2.67 and a beta of 1.06. The company has a quick ratio of 1.41, a current ratio of 1.94 and a debt-to-equity ratio of 0.54. The company’s 50-day moving average is $133.55 and its 200 day moving average is $128.29.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.